Sequenom +10.2% AH, receives European patent for detecting fetal aneuploidy

Sequenom (SQNM) shares surge 10.2% in AH trading after the company announces it has received a patent for "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing" from the European Patent Office.

The company states that it is "the first patent filing made in the EPO directed to such novel methods."

Comments (1)
  • Marty Chilberg
    , contributor
    Comments (579) | Send Message

    8 Jan 2014, 08:12 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs